In the News
Shelby Trieu
EDSA Announces 2025 Catalyst Award Honorees, ...

Congratulations to Project PROTECT, recently honored with the 2025 EDSA Catalyst Award for Outstanding Industry Collaboration from the End Drug Shortages Alliance. This award honors a multi-stakeholder partnership that has measurably improved drug access and strengthened supply resilience through cooperation, transparency, and innovation.

This award is especially meaningful because it reflects what Project PROTECT was built on from the very beginning: collaboration, ingenuity, and a shared commitment to protecting patients from essential medicine shortages. Together, Angels for Change, STAQ Pharma, and the Children’s Hospital Association designed and launched a model that brings hospitals, advocacy groups, manufacturers, and supply chain experts around one table to strengthen the stability of the drug supply chain. 

EDSA Announces 2025 Catalyst Award Honorees, Celebrating ‘Progress Through Partnership’ in Strengthening Drug Supply Resilience
In the News
Shelby Trieu
EDSA Advances Shared Mission to End Drug ...

The End Drug Shortages Alliance (EDSA), co-founded by Angels for Change and Vizient, has grown to more than 100 members across the healthcare supply chain. The article highlights how this expanding organization is advancing transparency, data-sharing and coordinated action to strengthen access to essential medicines. Recent progress includes a pilot with children’s hospitals and distributors focused on improving visibility for critical pediatric oncology drugs. The alliance’s continued growth reflects a shared commitment to building a more resilient, patient-centered supply chain.

EDSA Advances Shared Mission to End Drug Shortages with 100+ Members
A4C News
Shelby Trieu
2024 Annual Report
2024 Annual Report
In the News
Shelby Trieu
A4C Statement Featured in Congressional Hearing

Angels for Change Statement Included in Congressional Hearing on Strengthening the U.S. Health Care Supply Chain

Last month, the House Energy & Commerce Health Subcommittee held a critical hearing titled: “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain.”

Angels for Change submitted a formal statement for the record—bringing the voice of the patient directly to policymakers.

A4C Statement Featured in Congressional Hearing
In the News
Laura Bray
Bipartisan MAPS Act Introduced to Congress

New Legislation Takes Aim at Drug Shortages—Angels for Change Recognized in MAPS Act Launch

Angels for Change is officially recognized in the introduction of the bipartisan Mapping America’s Pharmaceutical Supply (MAPS) Act, a groundbreaking bill introduced by Representatives Doris Matsui (D-CA) and Dan Crenshaw (R-TX). This legislation directly addresses vulnerabilities in the drug supply chain by requiring greater transparency, mapping critical drug components, and identifying potential risks before they impact patient care

Bipartisan MAPS Act Introduced to Congress

In the News

EDSA Announces 2025 Catalyst Award Honorees, Celebrating ‘Progress Through Partnership’ in Strengthening Drug Supply Resilience

EDSA Announces 2025 Catalyst Award Honorees, Celebrating ‘Progress Through Partnership’ in Strengthening Drug Supply Resilience

Congratulations to Project PROTECT, recently honored with the 2025 EDSA Catalyst Award for Outstanding Industry Collaboration from the End Drug Shortages Alliance. This award honors a multi-stakeholder partnership that has measurably improved drug access and strengthened supply resilience through cooperation, transparency, and innovation.

This award is especially meaningful because it reflects what Project PROTECT was built on from the very beginning: collaboration, ingenuity, and a shared commitment to protecting patients from essential medicine shortages. Together, Angels for Change, STAQ Pharma, and the Children’s Hospital Association designed and launched a model that brings hospitals, advocacy groups, manufacturers, and supply chain experts around one table to strengthen the stability of the drug supply chain. 

EDSA Advances Shared Mission to End Drug Shortages with 100+ Members

EDSA Advances Shared Mission to End Drug Shortages with 100+ Members

The End Drug Shortages Alliance (EDSA), co-founded by Angels for Change and Vizient, has grown to more than 100 members across the healthcare supply chain. The article highlights how this expanding organization is advancing transparency, data-sharing and coordinated action to strengthen access to essential medicines. Recent progress includes a pilot with children’s hospitals and distributors focused on improving visibility for critical pediatric oncology drugs. The alliance’s continued growth reflects a shared commitment to building a more resilient, patient-centered supply chain.

Senate Passes NDAA with Key MAPS Act Provisions to Strengthen Drug Supply

Senate Passes NDAA with Key MAPS Act Provisions to Strengthen Drug Supply

Angels for Change celebrates the Senate’s passage of the National Defense Authorization Act (NDAA), which includes key provisions from the MAPS Act to strengthen transparency and coordination across the drug supply chain. This bipartisan step, led by Senators Peters, Lankford, Ernst, Cotton, Kaine, King, and Scott, advances meaningful progress toward a more reliable supply of essential medicines.

As the bill moves to the House, Angels for Change urges continued momentum to protect patients and prevent future drug shortages.

Ensuring Access to Medicines for Every Child

Ensuring Access to Medicines for Every Child

When a child is told the medicine they need to live isn’t available — we must act for change. The Children’s Hospital Association’s new article, “Ensuring Access to Critical Medicines for Children,” shines a light on the shared effort to protect pediatric patients from drug shortages and features Angels for Change’s work to strengthen medicine access nationwide.

A4C Founder Authors Chapter in The Cancer Journal

A4C Founder Laura Bray Authors Chapter in The Cancer Journal

We’re proud to share that A4C’s Founder and Chief Change Maker, Laura Bray, authored a chapter in The Cancer Journal. The piece takes a patient-centered approach to addressing drug shortages through a six-step pathway to a more resilient medicine supply chain.

Her chapter, “What an Oncology Drug Shortage Looks and Feels Like to Patients and What Can Be Done About It,” combines personal experience with actionable solutions to strengthen access to essential medicines.

“Ensuring patients receive care every single day, every single time, will take change. Patients deserve a resilient supply chain.” -Laura Bray, Angels for Change

We thank The Cancer Journal for dedicating an entire issue to this critical topic and elevating the voices of experts and advocates leading this work.

Hear from other Drug Shortage Experts in the full issue of The Cancer Journal below.

Read the PDF of Laura Bray’s chapter below.

The Cancer Journal Chapter PDF
The Cancer Journal Full Issue

Dr. Komorny Highlights A4C in Cancer Therapy Advisor

Dr. Komorny Highlights A4C in Cancer Therapy Advisor

Cancer Therapy Advisor recently published “Drug Shortages Threaten Cancer Care”, featuring insights from Dr. Ken Komorny of Moffitt Cancer Center.

While discussing solutions to address ongoing drug shortages, Dr. Komorny highlighted the work of Angels for Change, noting that “Angels for Change has proposed several ways to prevent or reduce the impact of shortages, including buffer inventory, stewardship, tracking, and early warning systems modeled after those in banking and agriculture.”

A4C Featured by CHA for Collaboration

A4C Featured by CHA for Collaboration

The Children’s Hospital Association recently highlighted Angels for Change in their article “Collaborating to End Drug Shortages.” The story explores how hospitals, manufacturers, and advocates are working together to strengthen the pediatric medicine supply chain. Through Project PROTECT, Angels for Change and partners like CHA are proactively safeguarding essential medicines so shortages don’t interrupt patient care. Together, we’re building a stronger, more reliable system that protects every child who depends on lifesaving treatments.